Skip to content

A Study Comparing the Effectiveness of Amrutadi Guggul and Fluconazole Tablets in the Treatment of Fungal skin infection .

A randomised controlled trial to evaluate the efficacy of Amrutadi Guggulu versus fluconazole tablet in the management of Dushivishajanya Dadru with special reference to tinea infection. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108297
Enrollment
50
Registered
2026-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Sane Guruji Aarogya Kendra.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed patients of Dushivishajanya Dadru (tinea infection) showing clinical findings of dadru that is kandu ,raga ,pidikotpati,utsanna mandala . 2.Patients presenting with clinical symptoms of Dushivishajanya Dadru for duration less than 6 monhts. 3.Patients presenting with any one or more above mentioned symptoms will be included in the study .

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating women. 2.Fungal infection other than Tinea corporis and tinea cruris,such tinea capitis ,tinea unguium ,tinea pedis ,tinea barbae ,tinea facie will exclude. 3.Patients who are suffering from any other type of skin disease like herpes zoster,eczema etc. 4.Patients on chemotherapy and radiation therapy . 5.Patients suffering from major medical illness.

Design outcomes

Primary

MeasureTime frame
Reduction clinical symotoms in patients of Dushivishajanya Dadru (tinea infection) after 45 days of treatmentTimepoint: 0,15th,30th,45th days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Vaibhav patil

MAMs Sumatibhai shah Ayurveda Mahavidyalya Malwadi Hadapsar pune 28

dr.vaibhav44@gmail.com8805260808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026